Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Opus Genetics Inc increased its cash reserves by 18.45%, or 7.87m. Cash Flow from Financing totalled 8.98m or 47.14% of revenues. In addition the company used 1.11m for operations while cash from investing was breakeven.
Cash flow per share | -0.589 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.56 |
---|---|
Tangible book value per share | 1.56 |
More ▼
Balance sheet in USDView more
Current ratio | 10.68 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼